EUVIMEDEUVIMED entdecken
Crossref

Biomimetic Multimodal Evaluation Reveals Enhanced Efficacy and Safety of Cyclosporine A Nanomicelles (CycloNex) for Advanced Dry Eye Management

Xing Dong, Kexin Cong, Yu Lu, Shaokun Yang, Yanan Sun, Jintao Hao, Yixuan Liu, Yaxin Zhang, Chun Liu, Chaoxing He, Yuhua Hao iD, Bai Xiang iD

Small · 2026-11 · 22 (63)

DOI: 10.1002/smll.74981 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, online erschienen am 02.08.2026. Verfasst von Xing Dong und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, School of Pharmaceutical Sciences, Hebei Medical University, Shijiazhuang, People's Republic of China. Hauptthemen laut MEDLINE: Cyclosporine, Micelles, Dry Eye Syndromes, Biomimetics. Die Arbeit nennt 59 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Hebei Province Funding Project for Introduced Overseas Personnel, Hebei Province Central Guidance Local Science and Technology Development Funding Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dry eye disease (DED), which affects over 30% of the global population, demands advanced therapeutic strategies to overcome ocular bioavailability challenges. We developed nanomicelles (RH40‐P188/RH40‐P407, CycloNex) for enhanced cyclosporine A (CsA) delivery through innovative biological validation platforms. The 15‐nm micelles demonstrated exceptional stability (3 months at 25°C) and deep tissue penetration (50 µm in 3D corneal spheroids), outperforming Cequa by 2.3‐fold in ex vivo rabbit corneal accumulation. A breakthrough microfluidic‐integrated 3D total corneal model revealed 82% prolonged ocular retention vs. Cequa, while our hyperosmotic cell platform showed 55% greater reactive oxygen species reduction and 44% lower TNF‐α expression. In vivo studies confirmed NM P188 ‐CsA's superior bioavailability, and corneal repair was completed within 14 days in mice with benzalkonium chloride‐induced dry eye. These findings, validated through six complementary biological models—including HET‐CAM irritation scoring (0.89 vs. Cequa's 1.34)—establish a new paradigm for ocular nanotherapeutic evaluation while demonstrating clinically translatable advantages over current standards.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CyclosporineMicellesDry Eye SyndromesBiomimeticsNanoparticlesAnimalsRabbitsCorneaMiceHumans

Stichwörter der Autor:innen

3D tissue microenvironment simulationcyclosporin Adry eye diseasemultimodal evaluationpolymeric micelle

Substanzen

CyclosporineMicelles

Autor:innen und Institutionen

  • Department of Pharmaceutics, School of Pharmaceutical Sciences, Hebei Medical University, Shijiazhuang, People's Republic of China.
  • Department of Ophthalmology, Fourth Hospital of Hebei Medical University, Shijiazhuang, People's Republic of China.
  • State Key Laboratory of New Pharmaceutical Preparations and Excipients, Hebei Medical University, Shijiazhuang, People's Republic of China.

ORCID-Profile: Yuhua Hao, Bai Xiang

Förderung

  • National Natural Science Foundation of China
  • Hebei Province Funding Project for Introduced Overseas Personnel
  • Hebei Province Central Guidance Local Science and Technology Development Funding Project
  • Shijiazhuang Basic Research Project

Zitieren

APA

Dong, X., Cong, K., Lu, Y., Yang, S., Sun, Y., Hao, J., Liu, Y., Zhang, Y., Liu, C., He, C., Hao, Y., & Xiang, B. (2026). Biomimetic Multimodal Evaluation Reveals Enhanced Efficacy and Safety of Cyclosporine A Nanomicelles (CycloNex) for Advanced Dry Eye Management. Small, 22(63). https://doi.org/10.1002/smll.74981

Vancouver

Dong X, Cong K, Lu Y, Yang S, Sun Y, Hao J, et al. Biomimetic Multimodal Evaluation Reveals Enhanced Efficacy and Safety of Cyclosporine A Nanomicelles (CycloNex) for Advanced Dry Eye Management. Small. 2026;22(63). doi:10.1002/smll.74981

BibTeX
@article{Dong2026,
  author = {Dong, Xing and Cong, Kexin and Lu, Yu and Yang, Shaokun and Sun, Yanan and Hao, Jintao and Liu, Yixuan and Zhang, Yaxin and Liu, Chun and He, Chaoxing and Hao, Yuhua and Xiang, Bai},
  title = {Biomimetic Multimodal Evaluation Reveals Enhanced Efficacy and Safety of Cyclosporine A Nanomicelles (CycloNex) for Advanced Dry Eye Management},
  journal = {Small},
  year = {2026},
  volume = {22},
  number = {63},
  doi = {10.1002/smll.74981}
}
Kostenlos starten →